Avidity Biosciences Inc.
June 12, 2024 - by Joey Ramson
RNA therapeutics company $RNA is reaching all-time highs today after posting initial data from its FORTITUDE trial for its experimental therapy del-brax (AOC 1020) in the treatment of a rare muscular disorder.
